These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9040189)

  • 1. Barrett's esophagus: does the incidence of adenocarcinoma matter?
    Cameron AJ
    Am J Gastroenterol; 1997 Feb; 92(2):193-4. PubMed ID: 9040189
    [No Abstract]   [Full Text] [Related]  

  • 2. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years.
    Drewitz DJ; Sampliner RE; Garewal HS
    Am J Gastroenterol; 1997 Feb; 92(2):212-5. PubMed ID: 9040193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry.
    O'Connor JB; Falk GW; Richter JE
    Am J Gastroenterol; 1999 Aug; 94(8):2037-42. PubMed ID: 10445525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding cancer incidence in Barrett's esophagus: light at the end of the tunnel.
    Corley DA
    J Natl Cancer Inst; 2011 Jul; 103(13):994-5. PubMed ID: 21680911
    [No Abstract]   [Full Text] [Related]  

  • 5. Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk.
    Provenzale D; Schmitt C; Wong JB
    Am J Gastroenterol; 1999 Aug; 94(8):2043-53. PubMed ID: 10445526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.
    Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE
    Am J Gastroenterol; 1997 Nov; 92(11):2012-6. PubMed ID: 9362182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort.
    Dulai GS; Shekelle PG; Jensen DM; Spiegel BM; Chen J; Oh D; Kahn KL
    Am J Gastroenterol; 2005 Apr; 100(4):775-83. PubMed ID: 15784018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etiology of Barrett's metaplasia and esophageal adenocarcinoma.
    Kim R; Weissfeld JL; Reynolds JC; Kuller LH
    Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):369-77. PubMed ID: 9149898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for Barrett's esophagus.
    Spechler SJ
    Rev Gastroenterol Disord; 2002; 2 Suppl 2():S25-9. PubMed ID: 12478241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and recognition of early esophageal neoplasia.
    Herszényi L; Pregun I; Tulassay Z
    Dig Dis; 2009; 27(1):24-30. PubMed ID: 19439957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenocarcinoma of the esophagus and Barrett's esophagus: a population-based study.
    Bytzer P; Christensen PB; Damkier P; Vinding K; Seersholm N
    Am J Gastroenterol; 1999 Jan; 94(1):86-91. PubMed ID: 9934736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incidence of adenocarcinoma and squamous cell carcinoma of the esophagus: Barrett's esophagus makes a difference.
    van Blankenstein M; Looman CW; Hop WC; Bytzer P
    Am J Gastroenterol; 2005 Apr; 100(4):766-74. PubMed ID: 15784017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer incidence in Barrett's esophagus: does it really matter, and who's counting anyway?
    Corley DA
    Gastrointest Endosc; 2008 Mar; 67(3):399-401. PubMed ID: 18294502
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk of adenocarcinoma in Barrett's oesophagus: population based study.
    Murray L; Watson P; Johnston B; Sloan J; Mainie IM; Gavin A
    BMJ; 2003 Sep; 327(7414):534-5. PubMed ID: 12958113
    [No Abstract]   [Full Text] [Related]  

  • 15. The problems with surveillance of Barrett's esophagus.
    Kahrilas PJ
    N Engl J Med; 2011 Oct; 365(15):1437-8. PubMed ID: 21995392
    [No Abstract]   [Full Text] [Related]  

  • 16. [Barrett esophagus: epidemiologic data and risk of becoming malignant].
    García Marcilla JA; Parrilla Paricio P; Ortiz Escandell MA; Martínez de Haro LF; Aguado Albasini JL; Molina Martínez J; Rodríguez Bermejo M
    Rev Esp Enferm Apar Dig; 1989 Nov; 76(5):419-23. PubMed ID: 2694239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenocarcinoma in Barrett's esophagus.
    Barret M; Chaussade S; Coriat R
    N Engl J Med; 2011 Dec; 365(26):2539; author reply 2539-40. PubMed ID: 22204731
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of Barrett's esophagus: cases and questions.
    Bresalier R
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S2-5. PubMed ID: 16399421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short segment Barrett's esophagus: ignorance may be bliss.
    Richter JE
    Am J Gastroenterol; 2006 Jun; 101(6):1183-5. PubMed ID: 16771934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence of esophageal adenocarcinoma among patients with nondysplastic Barrett's esophagus has been overestimated.
    Desai TK; Samala N
    Clin Gastroenterol Hepatol; 2011 Apr; 9(4):363-4; author reply 364-5. PubMed ID: 21115135
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.